YU4602A - Farmaceutske formulacije zaštićene od dejstva mikroorganizama - Google Patents

Farmaceutske formulacije zaštićene od dejstva mikroorganizama

Info

Publication number
YU4602A
YU4602A YU4602A YUP4602A YU4602A YU 4602 A YU4602 A YU 4602A YU 4602 A YU4602 A YU 4602A YU P4602 A YUP4602 A YU P4602A YU 4602 A YU4602 A YU 4602A
Authority
YU
Yugoslavia
Prior art keywords
pharmaceutical formulations
preserved pharmaceutical
phenoxyethanol
alone
combination
Prior art date
Application number
YU4602A
Other languages
English (en)
Inventor
Atef Gayed
Original Assignee
Aventis Pharmaceuticals Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharmaceuticals Inc. filed Critical Aventis Pharmaceuticals Inc.
Publication of YU4602A publication Critical patent/YU4602A/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules

Abstract

Ovaj pronalazak se odnosi na upotrebu benzetonijumhlorida, samog ili u kombinaciji sa fenoksietanolom ili feniletilalkoholom, koja farmaceutskim preparatima daje antimikrobnu aktivnost. Ovaj pronalazak takodje daje postupke za upotrebu benzetonijumhlorida, samog ili u kombinaciji sa fenoksietanolom ili feniletilalkoholom, za inhibiranje rasta mikroba u farmaceutskim preparatima.[The present invention is directed to the use of the benzethonium chloride, alone or in combination with phenoxyethanol or phenyl ethyl alcohol, to provide anti-microbial activity in pharmaceutical compositions. The present invention also provides methods of using benzethonium chloride, alone or in combination with phenoxyethanol or phenyl ethyl alcohol, to inhibit microbial growth in pharmaceutical compositions.
YU4602A 1999-07-22 2000-07-21 Farmaceutske formulacije zaštićene od dejstva mikroorganizama YU4602A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22881599P 1999-07-22 1999-07-22

Publications (1)

Publication Number Publication Date
YU4602A true YU4602A (sh) 2005-06-10

Family

ID=22858657

Family Applications (1)

Application Number Title Priority Date Filing Date
YU4602A YU4602A (sh) 1999-07-22 2000-07-21 Farmaceutske formulacije zaštićene od dejstva mikroorganizama

Country Status (21)

Country Link
US (1) US7109161B1 (sh)
EP (1) EP1200128A1 (sh)
JP (1) JP2003520777A (sh)
KR (2) KR20020032534A (sh)
CN (1) CN1371287A (sh)
AU (1) AU777410C (sh)
BR (1) BR0012674A (sh)
CA (1) CA2378892C (sh)
CZ (1) CZ2002265A3 (sh)
EA (1) EA007070B1 (sh)
EE (1) EE200200038A (sh)
HK (1) HK1050317A1 (sh)
HR (1) HRP20020160A2 (sh)
HU (1) HUP0202235A3 (sh)
IL (1) IL147756A (sh)
NO (1) NO20020304L (sh)
NZ (1) NZ516736A (sh)
PL (1) PL353026A1 (sh)
WO (1) WO2001007086A1 (sh)
YU (1) YU4602A (sh)
ZA (1) ZA200200743B (sh)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020032534A (ko) 1999-07-22 2002-05-03 게리 디. 스트리트, 스티븐 엘. 네스비트 보존 제약 제형
US20020107469A1 (en) * 2000-11-03 2002-08-08 Charles Bolan Apheresis methods and devices
AU2003220125B2 (en) 2002-03-20 2006-06-15 Mannkind Corporation Inhalation apparatus
EP1686976A2 (en) * 2003-11-05 2006-08-09 Santarus, Inc. Combination of proton pump inhibitor and sleep aid
DE102004011663B4 (de) * 2004-03-10 2006-04-27 Bioceuticals Arzneimittel Ag Erythropoietin-Flüssigformulierung
US8338648B2 (en) 2004-06-12 2012-12-25 Signum Biosciences, Inc. Topical compositions and methods for epithelial-related conditions
PL1786784T3 (pl) 2004-08-20 2011-04-29 Mannkind Corp Kataliza syntezy diketopiperazyn
EP2322180B1 (en) 2004-08-23 2015-05-27 MannKind Corporation Diketopiperazine salts for drug delivery
US9028852B2 (en) * 2004-09-07 2015-05-12 3M Innovative Properties Company Cationic antiseptic compositions and methods of use
RU2390325C2 (ru) 2005-09-14 2010-05-27 Маннкайнд Корпорейшн Способ приготовления лекарственного препарата, основанный на увеличении сродства активных агентов к поверхностям кристаллических микрочастиц
RU2403059C2 (ru) 2006-02-22 2010-11-10 Маннкайнд Корпорейшн Способ улучшения фармацевтических свойств микрочастиц, содержащих дикетопиперазин и активный агент
BRPI0710287A2 (pt) 2006-04-18 2012-05-29 Ekr Therapeutics Inc composição farmacêutica, método para tratar um indivìduo quanto à pressão sangüìnea elevada, complexo de inclusão, e, métodos para tratar e evitar elevações agudas da pressão sangüinea em um indivìduo humano e para induzir a hipotensão em um indivìduo humano.
US20080103169A1 (en) 2006-10-27 2008-05-01 The Curators Of The University Of Missouri Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same
US20090069418A1 (en) * 2007-04-25 2009-03-12 Alkayed Nabil J Compositions and Methods for the Treatment of Disorders Associated with Aberrant Vasodilation
DE102007054794A1 (de) * 2007-11-13 2009-05-14 Agilan Gmbh Wässrige Eisen-Dextran-Zubereitung mit ein oder mehreren Verbindungen der para-Hydroxy-Benzoesäureester und/oder deren Salzen
AU2008333929A1 (en) * 2007-12-03 2009-06-11 Signum Biosciences, Inc. Acid mimic compounds for the inhibition of isoprenyl-S-cysteinyl methyltransferase
CA2716367C (en) 2008-02-20 2015-05-26 The Curators Of The University Of Missouri Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
US8636001B2 (en) 2008-06-13 2014-01-28 Mannkind Corporation Dry powder inhaler and system for drug delivery
DK2609954T3 (da) 2008-06-20 2022-02-14 Mannkind Corp Interaktivt apparat til realtidsafbildning af inhalationspræstationer
RU2497679C2 (ru) 2008-10-02 2013-11-10 Милан Инк. Способ получения многослойного клеящегося ламинированного материала
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
TW201138782A (en) 2010-04-26 2011-11-16 Besins Healthcare Lu Sarl Low-oil pharmaceutical emulsion compositions comprising progestogen
EP2582421A1 (en) 2010-06-21 2013-04-24 MannKind Corporation Dry powder drug delivery system and methods
KR101805087B1 (ko) 2010-09-16 2017-12-05 주식회사 엘지화학 높은 방부력을 제공하는 오일 주사 제형
WO2012135765A2 (en) * 2011-04-01 2012-10-04 Mannkind Corporation Blister package for pharmaceutical cartridges
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
US20130011494A1 (en) * 2011-07-10 2013-01-10 Mohammad Rahimi Composition for treating decubitus ulcers in diabetic and non-diabetic patients
CN102993031B (zh) 2011-09-19 2014-03-26 北京桑普生物化学技术有限公司 一种制备芳基多氧烷基季铵类化合物的方法
CN103945859A (zh) 2011-10-24 2014-07-23 曼金德公司 用于治疗疼痛的方法和组合物
US9802012B2 (en) 2012-07-12 2017-10-31 Mannkind Corporation Dry powder drug delivery system and methods
MX2020009878A (es) 2013-07-18 2022-07-27 Mannkind Corp Composiciones farmaceuticas en polvo seco estables al calor y metodos.
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
DE102016000277A1 (de) 2016-01-15 2017-07-20 Beiersdorf Ag Kosmetische Zubereitungen enthaltend Benzethonium Chlorid und Diole
JP7220655B2 (ja) * 2016-12-16 2023-02-10 ヴァーテラス ホールディングス エルエルシー 第四級アミン配合物及びその使用
US11364225B2 (en) * 2019-08-21 2022-06-21 Bn Intellectual Properties, Inc. Pharmaceutical formulation for treating symptoms of migraine and cluster headaches, and method of using the same

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3489837A (en) * 1968-07-11 1970-01-13 Leroy J Hyman Synergistic antiseptic composition consisting of 9-aminoacridine hydrochloride and benzethonium chloride
US4053628A (en) 1971-05-12 1977-10-11 Fisons Limited Composition
JPS6045849B2 (ja) 1980-08-25 1985-10-12 林原 健 ヒトエリトロポエチンの製造方法
US4506018A (en) 1982-12-30 1985-03-19 Becton, Dickinson And Company Blood diluent
US4703008A (en) 1983-12-13 1987-10-27 Kiren-Amgen, Inc. DNA sequences encoding erythropoietin
JPS6197229A (ja) 1984-10-18 1986-05-15 Chugai Pharmaceut Co Ltd 安定なエリトロポエチン製剤
JPH0651637B2 (ja) 1985-03-28 1994-07-06 エーザイ株式会社 ペプタイドの吸着防止組成物
US5045529A (en) * 1989-03-27 1991-09-03 Bionostics, Inc. Tonometric fluid for blood gas and co-oximetry instruments
JP3249147B2 (ja) 1990-06-01 2002-01-21 キリン−アムジエン・インコーポレーテツド 生理活性蛋白含有経口製剤
DE4126983A1 (de) 1991-08-15 1993-02-18 Boehringer Mannheim Gmbh Verfahren zur herstellung von humanprotein-enthaltenden, konservierten arzneimitteln fuer infusions- oder injektionszwecke
US5661125A (en) 1992-08-06 1997-08-26 Amgen, Inc. Stable and preserved erythropoietin compositions
ES2079320B1 (es) 1994-05-17 1996-10-16 Cusi Lab Disolucion oftalmica a base de un diclofenaco y tobramicina y sus aplicaciones.
US5611464A (en) 1995-05-30 1997-03-18 Ciba Geigy Corporation Container for preserving media in the tip of a solution dispenser
US6022551A (en) 1998-01-20 2000-02-08 Ethicon, Inc. Antimicrobial composition
US5997893A (en) 1998-01-20 1999-12-07 Ethicon, Inc. Alcohol based anti-microbial compositions with cosmetic appearance
KR100693263B1 (ko) 1999-07-22 2007-03-13 아벤티스 파마슈티칼스 인크. 다중 투여형 에리트로포이에틴 제형
KR20020032534A (ko) 1999-07-22 2002-05-03 게리 디. 스트리트, 스티븐 엘. 네스비트 보존 제약 제형

Also Published As

Publication number Publication date
IL147756A0 (en) 2002-08-14
CN1371287A (zh) 2002-09-25
HUP0202235A3 (en) 2004-05-28
NZ516736A (en) 2004-02-27
EA200200072A1 (ru) 2003-02-27
WO2001007086A1 (en) 2001-02-01
AU777410C (en) 2006-08-17
PL353026A1 (en) 2003-10-06
NO20020304L (no) 2002-03-21
US7109161B1 (en) 2006-09-19
CZ2002265A3 (cs) 2002-08-14
CA2378892C (en) 2008-07-15
IL147756A (en) 2005-12-18
KR20020032534A (ko) 2002-05-03
NO20020304D0 (no) 2002-01-21
AU6232500A (en) 2001-02-13
EA007070B1 (ru) 2006-06-30
EP1200128A1 (en) 2002-05-02
HUP0202235A2 (hu) 2002-11-28
HK1050317A1 (zh) 2003-06-20
AU777410B2 (en) 2004-10-14
KR20070116181A (ko) 2007-12-06
BR0012674A (pt) 2002-09-17
JP2003520777A (ja) 2003-07-08
EE200200038A (et) 2003-04-15
CA2378892A1 (en) 2001-02-01
HRP20020160A2 (en) 2003-10-31
ZA200200743B (en) 2003-06-25

Similar Documents

Publication Publication Date Title
YU4602A (sh) Farmaceutske formulacije zaštićene od dejstva mikroorganizama
HK1094320A1 (en) Antiseptic compositions, methods and systems
TW200744639A (en) Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents
GEP20063885B (en) Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
MXPA05006685A (es) Antibioticos que contienen complejos de acido borinico y metodos de uso.
ITMI20041550A1 (it) Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide
ATE464055T1 (de) Topische zusammensetzungen mit phosphorylierten polyphenolen
PL1663168T3 (pl) Preparaty nikotyny i ich zastosowanie
AU2274201A (en) Compounds and compositions for delivering active agents
IL153297A0 (en) Compounds and compositions for delivering active agents
ATE326983T1 (de) Aminoalkohole enthaltende ophthalmische zusammensetzungen
UY26082A1 (es) Derivados de 1,4-diazabiciclo [3.2.2] nonan-4-carboxilato y -carboxamidas, su preparacion y su aplicacion en terapeutica
HK1088845A1 (en) Use of parthenolide derivatives as antileukemic and cytotoxic agents
SE9900961D0 (sv) Novel compounds
AU3227700A (en) Skin sanitizing compositions
SE9802208D0 (sv) Novel compounds
WO2002070464A3 (en) Hydrazones and their therapeutic use
HK1098352A1 (en) Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis
DK1228097T3 (da) Antimikrobiel aktivitet af den förste kationiske humane lactoferrin-klynge
ATE270115T1 (de) Behandlung einer intrazelluläre infektion
AU2001289714A1 (en) Benzofuran derivatives and their use as antibacterial agents
MXPA05014184A (es) Utilizacion de acido hialuronico para la preparacion de composiciones para el tratamiento de aftas en la cavidad oral.
SE9802209D0 (sv) Novel compounds
AU2002223796A1 (en) Pleuromutilin derivatives with antimicrobial activity
AU6076500A (en) Hypoestoxides, derivatives and agonists thereof for use as antiparasitic agents